课题基金 / 基金详情

Analysis of interferon related gene regulation as a proapoptotic function against hepatocellular carcinoma

Analysis of interferon related gene regulation as a proapoptotic function against hepatocellular carcinoma
干扰素相关基因调控对肝细胞癌的促凋亡作用分析
批准号:
15590650
负责人:
SAKAGUCHI Kohsaku
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

SAKAGUCHI Kohsaku的其他基金

相似基金

相关文献

中文摘要
翻译
干扰素(IFN)联合5-氟尿嘧啶(5-FU)治疗晚期肝细胞癌疗效显著。干扰素α2被广泛用于慢性肝病。但干扰素α8是最有效的诱导几种癌细胞凋亡的亚型。在本研究中,我们探讨了干扰素α2或α8联合5-FU诱导肝癌细胞凋亡的分子机制。检测了5种肝癌细胞株(Hep3B、HuH7、HLE、PLC/PRL/5和HepG2)在不加或不加5-FU的情况下,干扰素α诱导细胞凋亡的能力。对干扰素和5-FU联合作用最敏感的是Hep3B。Caspase-3、-9,尤其是caspase-8活性在干扰素和5-FU联合用药时明显高于单用干扰素或5-FU组。当5-FU加入两种干扰素α处理时,JAK-STAT途径转录因子ISRE被更协同地激活。对caspase-3,-8,9,c-jun氨基末端激酶(JNK)、磷脂酰肌醇3-激酶(PI3K)和p38丝裂原活化蛋白激酶(P38 MAPK)的抑制表明,抑制caspase-8是减少干扰素和/或5-FU诱导细胞凋亡的最有效的治疗方法。在JAK1和ISGF3g沉默的Hep3B细胞中,干扰素诱导的凋亡和caspase-8的激活水平被取消,甚至与5-FU联合使用也是如此。虽然干扰素α8比α2更有效地诱导肝癌细胞的凋亡,并且在芯片分析中呈现不同的簇,但JAK-STAT和caspase的激活状态是相似的,我们认为caspase-8是控制干扰素和5-FU诱导肝癌细胞凋亡的最重要的因素。
英文摘要
Interferon (IFN) combined with 5-Fluorouracil (5-FU) treatment is recently reported to show marked effects in patients with advanced hepatocellular carcinoma (HCC). IFN alpha 2 is widely provided for chronic liver diseases. But IFN alpha 8 is the most effective subtype to induce apoptosis in several cancer cell lines. In this study, we investigated the molecular mechanisms of apoptosis induction in hepatoma cell lines with IFN alpha 2 or alpha 8 in combination with 5-FU. Five hepatoma cell lines (Hep3B, Huh7, HLE, PLC/PRL/5, and HepG2) were tested for apoptosis inducibility by IFN alpha in the absence or presence of 5-FU. Hep3B was the most apoptosis sensitive to IFN plus 5-FU treatment. Caspases-3, -9, and especially caspase-8 activities were higher with IFN alpha plus 5-FU than IFN or 5-FU alone. The JAK-STAT pathway transcriptional factor ISRE was activated more synergistically when 5-FU was added to both IFN alpha treatments. Inhibition of caspase-3,-8,9,c-Jun N-terminal kinase (JNK), phosphatidylinositide 3-kinase (PI3K), and p38 mitogen-activated protein kinase (p38 MAPK) revealed that caspase-8 inhibition was the most effective treatment to decrease apoptotic effects of IFN and/or 5-FU. In JAK1, and ISGF3g-silenced Hep3B cells, the apoptosis induction and caspase-8 activation levels by IFN, even in combination with 5-FU, were abrogated. Although IFN alpha 8 induced apoptosis more effectively than alpha 2 and showed different cluster in microarray analysis, the JAK-STAT and caspase activation status were similar.We conclude that caspase-8 is the most important factor that controls IFN-and 5-FU- induced apoptosis in hepatoma cell lines.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to Corticosteroid
患有 HBV 和 HCV 阴性自身免疫性肝炎且对皮质类固醇反应不佳的女性患肝细胞癌
DOI: --
发表时间: 2005
期刊: Internal Medicine 44-9
影响因子: --
作者: [Miyake, Y., Iwasaki, Y., Shiratori, Y., et. al.]
通讯作者: et. al.
Risk factors for hepatocellular carcinoma in fepatitis C patients with sustained virologic response to interferon therapy.
对干扰素治疗有持续病毒学反应的丙型肝炎患者发生肝细胞癌的危险因素。
DOI: --
发表时间: 2004
期刊: Liver Int. 24
影响因子: --
作者: [Iwasaki Y, Sakaguchi K, et al.]
通讯作者: et al.
DOI: --
发表时间: 2004
期刊: 肝臓 45(1)
影响因子: --
作者: [小池和子, 高木章乃夫, 坂口孝作 他]
通讯作者: 坂口孝作 他
DOI: 10.1111/j.1478-3231.2004.0956.x
发表时间: 2004-12-01
期刊: LIVER INTERNATIONAL
影响因子: 6.7
作者: [Iwasaki, Y, Takaguchi, K, Shiratori, Y]
通讯作者: Shiratori, Y
14
    Abnormalities of immune regulation in autoimmune hepatitis and their modulation by TGF-β
    • 批准号:
      09670552
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      1997
    • 负责人:
      SAKAGUCHI Kohsaku
    • 依托单位:
    国内基金
    海外基金
    中药活性成分土木香内酯靶向 TXNL2 通过caspase-3/GSDME 介导的细胞焦亡抗未分化甲状腺癌的机制研究
    • 批准号:
      ZCLQN26H2801
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      温庆良
    • 依托单位:
    壮骨止痛胶囊通过NLRP3/Caspase-1/GSDMD信号通路调控神经肽介导PMOP大鼠脑-肠-骨轴的机制研究
    • 批准号:
      2026JJ81070
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈沙
    • 依托单位:
    骨痹汤调控NLRP3/ASC/Caspase-1介导的细胞焦亡治疗膝骨关节炎的作用及机制研究
    • 批准号:
      2026JJ80380
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      郑艳艳
    • 依托单位:
    TIRAP调控NLRP3/Caspase-1/GSDMD通路诱导KOA软骨细胞焦亡机制的研究